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Although alkyl epoxides are difficult to synthesize in 
enantiomerically pure form they can often be prepared 
by the enantioselective hydrolysis of racemic epoxide. 
The best methods for this transformation are all catalytic 
and they illustrate the complementary role that biological 
and synthetic catalysts can play in organic chemistry. 
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Why should researchers in the biological sciences care 
about epoxides? 
Organic chemists have devoted tremendous effort to the 
preparation of enantiomerically pure epoxides and the use 
of epoxides in organic synthesis. Although it is assumed 
that the organic chemists among the readership of C&m- 
istq &Biology are probably convinced of the value of this 
functional group, the epoxides may not seem as important 
to those scientists who aren’t in the business of making 
molecules. There are, for purposes of this discussion, two 
practical reasons to care about epoxides. First, epoxides 
are a common structural element in a great many biologi- 
cally active molecules! both simple and complex 
(Figure 1). Second, they undergo facile, stereoselective 
ring-opening reactions with a wide range of nucleophiles, 
making them versatile starting materials and intermedi- 
ates for the synthesis of compounds that have interesting 
biological activity (Figure 2) [l,‘Z]. 
The nature of the ring-opening reactions raises an impor- 
tant issue - that of chirality. The vast majority of com- 
pounds that have an interesting biological function are 
Figure 1 
Enantioselective epoxide hydrolysis: catalysis involving 
chiral, and the different stereoisomers often have differ- 
ent biological activities. As epoxides are involved in the 
preparation of biologically useful compounds, it is advan- 
tageous that epoxides are stereochemically pure when 
used as a substrate. 
Why should anyone care about epoxide hydrolysis? 
Effective methods have now been discovered for the 
enantioselective conversion of several classes of alkenes to 
the corresponding epoxides. The two most extensively 
developed reactions - the Sharpless [3] and Jacobsen [4] 
epoxidations - allow the catalytic, enantioselective 
preparation of epoxides from allylic alcohols and conju- 
gated olefins, respectively (Figure Z), and these processes 
now provide routine access to many of the substituted 
epoxides within these structural categories. Although the 
enzymatic oxidation of alkenes has met with some success 
[S], methods for the enantioselective preparation of epox- 
ides from monosubstituted or alkyl olefins have largely 
remained elusive. As illustrated in Figure 1, this is not for 
want of importance. 
In the absence of direct chemical methods for the enantio- 
selective synthesis of terminal or alkyl epoxides, numerous 
alternative procedures have been explored, including indi- 
rect synthesis and stoichiometric resolution using an exter- 
nal chiral reagent [6-81. An intriguing alternative to these 
strategies is the preparation of enantiomerically pure epox- 
ides by kinetic resolution [9], a process in which one of the 
enantiomers of a racemic epoxide is selectively degraded, 
leaving behind the other enantiomer. When the selective 
process is the catalytic hydrolysis of the epoxide with 
water (Figure 3), the transformation has the additional 
appeal of using an environmentally benign compound 
(water) as the only stoichiometric reagent, and providing a 
potentially valuable byproduct, the chiral diol. (Effective 
methods for the direct enantioselective synthesis of diols 
from olefins are available, however [lo].) 
Biologically important epoxides. 
Ethylene oxide 
Disinfectant and fungicide Juvenile insect hormone I (JH I) 0 OH 0 
Insect growth regulator 
Epothilone A 
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Figure 2 
From Sharpless epoxidation 0 Immune suppressant 
Me0 
Dlltiazem” 
From Jacobsen epoxidation Antihypertensive agent 
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The use of epoxides in the synthesis of 
biologically active molecules. The enantio- 
selective epoxidation of an allylic alcohol was 
a key transformation early in the synthesis of 
the immune suppressant FK-506 by Schreiber 
et a/. [ll. Similarly, the enantioselective 
epoxidation of a cinnamate ester served as 
the basis for Jacobsen’s synthesis of the 
antihypertensive agent Diltiszem@ [2]. 
(AC, acetyl; Me, methyl; Pr, isopropyl.) 
As elegant as the hydrolytic kinetic resolution (HKR) 
shown in Figure 3 may be in principle, it has a built-in 
limitation: the yield of enantiomerically pure epoxide is 
limited to a maximum of 50%.~ However, many useful 
alkyl epoxides are either commercially available at low 
cost or can be readily prepared from the corresponding 
olefins, making HKR processes currently one of the most 
effective methods for gaining enantioselective access to 
this important class of compounds. Indeed, as will be dis- 
cussed, for some classes of alkyl epoxides HKR is far and 
away the method of choice. 
Available methods for HKR 
To date, all of the effective methods for the HKR of epox- 
ides are catalytic, so the benefits of catalytic reagents for 
asymmetric transformation will not be discussed at length 
here. (Among these benefits are lowered net reagent con- 
sumption, minimized waste generation, and often, as in 
the present case, access to enantioselective reactions for 
which there is no noncatalytic alternative.) The catalysts 
known to effect epoxide HKR may be divided into three 
categories: enzymes, of both microbial and mammalian 
origin, catalytic antibodies derived from the mammalian 
immune system, and synthetic catalysts. 
The first class of catalysts - enzymes - has been the most 
extensively studied, whereas the use of catalytic antibodies 
Figure 3 
and synthetic catalysts in epoxide HKR have only recently 
been demonstrated, each by a single published example. As 
might be expected, each type of catalyst has characteristic 
strengths and weaknesses. These will be discussed with an 
eye towards practical utility. Where possible, literature 
examples will be evaluated using several criteria previously 
enumerated for the practical comparison of asymmetric cat- 
alytic systems: enantioselectivity (expressed as % enan- 
tiomeric excess (ee), % ee = % major enantiomer - % minor 
enantiomer); the amount of catalyst required to transform a 
given amount of starting material (and the volume of the 
solution in which the transformation is carried out); the 
accessibility and cost of the catalyst; and how the method 
compares to alternative strategies [ll]. The last criterion 
will be addressed, in part, by focusing on reactions for 
which equivalent direct alternatives do not exist. 
Enzymatic catalysts for HKR - an overview 
Unlike the other methods for HKR, enzymatic resolution 
has been known long enough to have a history to relate. 
The class of enzymes known to be active in the hydrolysis 
of epoxides are, unsurprisingly, called epoxide hydrolases. 
Epoxide hydrolases are present in most living organisms, 
including fungi, bacteria, plants, insects and mammals 
[l&13]. Although certain specialized epoxide hydrolases 
have very specific regulatory functions (such as the enzyme 
responsible for hydrolyzing juvenile insect hormone I, 
Hydrolytic kinetic resolution (HKR) of an alkyl 
HKR 
o+R + &OH - 
HKR 
OAR + .A? - 
epoxide. 
Selective hydrolysis 
of (R)-enantiomer 
(R) Selective hydrolysis 
of Wenantiomer 
Chemistry & Biology 
Minireview Epoxide hydrolysis Finney R75 
Figure 4 
General mechanism for the enzymatic 
hydrolysis of epoxides. 
/--‘--i 
Hz0 (enzyme) 
HO,p-“, 
Nucleophilic attack on the epoxide 
by an active-site carboxylate... 
. ..leads to an enzyme-bound 
glycol intermediate... 
. ..which liberates the diol 
upon hydrolysis by water. 
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Figure 1) [14], the predominant collective role of epoxide 
hydrolases is xenobiotic detoxification by degrading exoge- 
nous epoxides or the oxidation products of exogenous 
olefinic compounds. Although the enzymes from different 
organisms, and even enzymes from within the same organ- 
ism, do not behave in exactly the same way, the general 
consensus is that they are all derived from a common evolu- 
tionary ancestor, a predecessor that also gave rise to the 
haloalkane hydrolases. Several of the epoxide hydrolases 
have been characterized at the level of the gene (corroborat- 
ing the preceding assertion of a common ancestor), and in 
some cases have been successfully overexpressed [l&13]. 
A general mechanism for enzymatic epoxide hydrolysis is 
shown in Figure 4. The most extensive mechanistic 
studies have been conducted on enzymes of mammalian 
origin [15], but in the light of the qualitative similarities 
among the epoxide hydrolases of different species, it is 
widely accepted that most epoxide hydrolases function in 
a similar manner. Two features of the reaction in Figure 4 
should be noted, as the illustration somewhat understates 
their importance. First, epoxide opening by the active-site 
carboxylate proceeds with inversion of configuration at the 
center undergoing nucleophilic attack. Second, nucle- 
ophilic opening of the epoxide can occur at either carbon 
center (even with terminal epoxides), and enzymatic 
hydrolysis is not uniformly regioselective. Epoxide hydro- 
lases from different species have widely differing regio- 
selectivities, and span the range from completely selective 
to completely nonselective. 
Figure 5 
Representative epoxides that can be resolved 
to > 95% ee by HKR with epoxide hydrolases. 
Enzymatic catalysts for HKR - selected case studies 
Enzymatic catalysis is often characterized by exquisite 
selectivity coupled with limited substrate scope. HKR by 
epoxide hydrolases is no exception, and it is usually the 
case that a given enzyme, if highly selective, exhibits this 
selectivity for only a few substrates. The number of 
known epoxide hydrolases partially offsets this limitation, 
however; there are now established, if not always practical, 
enzymatic resolutions for several terminal epoxides and at 
least representative members of most structural classes of 
alkyl epoxides (Figure 5). To illustrate the salient features 
of HKR by epoxide hydrolases, three of these substrates 
will be examined in greater detail. 
The HKR of trans-Z-butene oxide (Figure 6) demon- 
strates the potential of epoxide hydrolases in organic 
chemistry - an inexpensive racemic epoxide is resolved 
to a precious chiral compound with yield and ee close to 
the theoretical maximum, a result for which there is 
simply no nonenzymatic equivalent [16]. Several limita- 
tions are also apparent, however. First, the yeast strain in 
question (Rhodotomla glut&is CIMW 147) is not commer- 
cially available. Second, only one enantiomer of the 
epoxide can be prepared in this manner, another signature 
limitation of enzymatic synthesis. Third, the reaction is 
carried out by incubating the epoxide in the fungal fer- 
mentation. Although this is not a concern for those already 
in the habit of routinely culturing fungi, it represents a sig- 
nificant impediment for synthetic chemists who have no 
background in such techniques. Finally, even those for 
OAc 
H,C$/s 
OZN 
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Fiaure 6 
HsCpCH3 (?) 
R. glutinis 
* 
whole cells 
H3CvcH3 + ,3,+H3 
OH 
Weight of 
substrate 
0.0149 
Weight of Volumetric Yield ee 
catalyst productivity Epoxide Diol Epoxide Diol 
lg = 0.4 g I-’ 47% - z 98% (meso) 
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whom culturing yeast is not an intimidating prospect will 
have to come to terms with the fact that the volumetric 
productivity is rather low, and a large quantity of catalyst 
is required to transform a proportionally small quantity of 
substrate. (Extrapolating from the literature report, 
preparing 1 g of enantiomerically pure epoxide would 
require over 150 g, dry weight, of yeast cells.) 
It should be noted that the large quantity of catalyst 
required (the catalyst weight-loading) for the above pro- 
cedure is a reflection of the use of whole fungal cells - 
the active enzyme is only a small proportion of the 
weight of the entire organism. In practice, however, the 
amount of material that a researcher must handle is really 
the relevant parameter. The use of purified, or even par- 
tially purified, preparations of microbial and mammalian 
epoxide hydrolases leads to significantly lower catalyst 
weight-loadings, but the requirement of an isolated 
enzyme that is not commercially available moves the 
application even further out of the reach of most experi- 
mental chemists. (This is especially the case for mam- 
malian epoxide hydrolases, which are typically isolated in 
very small quantities from fresh liver.) 
Cautionary notes aside, epoxide hydrolases do have practi- 
cal application; two illustrative examples are shown in 
Figure 7 
Nearly perfect HKR of a trans-dialkyl epoxide 
by a fungal epoxide hydrolase. R. glutinis, 
Rhodotorula g/Minis CIMW 147. 
Figures’ 7 and 8, both mediated by the fungus Aspergillzl 
n&y-. In the first case (Figure 7) [17], which employs a 
whole-cell preparation of the fungus, an analog of the 
juvenile insect hormones known as Bower’s compound 
was resolved on preparative scale. Although the diol prod- 
ucts of this type can be prepared with greater enantiose- 
lectivity by other means [IO], the ability to obtain gram 
quantities of nearly enantiomerically pure epoxide from a 
1 1 fermentation is quite attractive. Even more impressive 
is the recently reported resolution of p-nitrostyrene oxide 
(Figure 8) [18], a precursor to the P-blocker Nifknalol. 
This reaction has the highest volumetric productivity 
reported for an epoxide-hydrolase-mediated HKR. 
Catalytic antibodies for HKR 
For those not familiar with this area of research, antibody 
catalysts are usually identified by the following sequence: 
inoculating an animal with a hapten (such as bovine 
serum albumin) to which a transition-state analog for the 
reaction of interest has been attached; isolating the anti- 
bodies raised by the immune system in response to this 
hapten; identifying the antibodies capable of binding the 
transition-state analog and catalyzing the reaction; and 
cloning the antibodies to obtain sufficient amounts of 
monoclonal antibody for further study [19,20]. The 
potential of antibodies to serve as catalysts for important 
.$: A.niger - HcpoAc +HcgoAc 
3 3 3 3 3 3 
Weight of Weight of Volumetric Yield 
substrate catalyst productivity Epoxide Diol Epoxidy Diol 
59 - = 2g I-’ 42% 43% 96% 40% 
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Application of epoxide hydrolases to the 
preparation of Bower’s compound, an analog 
of the juvenile insect hormones. 
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Figure 8 
Preparative epoxide-hydrolase-mediated 
resolution of a styrene oxide. 
A. niger 
* 
partially purified OnN 
Weight of Weight of 
substrate catalyst 
108 mg 103 mg 
Volumetric 
productivity 
27 g I-’ 
Yield 
Epoxide Diol 
47 % - 
ee 
Epoxide Diol 
> 99 % - 
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synthetic transformations has been a topic of extensive 
discussion in recent years. This potential has seen prepar- 
ative (i.e., gram-scale) realization in only a few cases, 
such as the HKR of a fluorinated ester [‘Zl], but catalytic 
antibodies still hold the tantalizing prospect of bridging 
the gap between the tremendous selectivities of enzymes 
and the broad substrate scope more often associated with 
synthetic catalysts. 
To date, there has been only one report of the application 
of catalytic antibodies to enantioselective epoxide hydroly- 
sis (Figure 9) [ZZ]. Reactions employing catalytic antibod- 
ies usually have many of the same restrictions associated 
with enzymatic catalysis: their execution requires signifi- 
cant expertise generally not possessed by the researchers 
most interested in preparing enantiomerically pure epox- 
ides, and the procedures are often plagued by high catalyst 
weight-loading and low volumetric productivity. Although 
the present system does not appear to be exempt from 
these limitations, the data presented in Figure 9 were 
extracted from a preliminary communication, and the reac- 
tion has almost certainly been optimized further. 
Synthetic catalysts for HKR 
The recent report of the HKR of terminal epoxides by 
chiral (salen)Co catalysts represents the first successful 
application of synthetic catalysts to this reaction (Figure 10; 
Figure 9 
[23], E.N. Jacobsen, unpublished observations). The cata- 
lyst system is remarkable in almost every respect: it 
employs relatively low weight-loadings of an inexpensive, 
reusable, commercially available catalyst; it exhibits 
enzyme-like selectivity for a range of terminal tpoxides, 
and can be applied to the preparation of either epoxide 
enantiomer; and it requires no solvent (just epoxide, = 0.5 
equivalents of water, and the catalyst), and, as such, its vol- 
umetric productivity exceeds that of almost any catalytic 
reaction known. 
The method is currently the most convenient and effective 
for the large-scale preparation of optically active monosub- 
stituted epoxides. The practical use of this reaction is 
demonstrated by the hydrolysis of propylene oxide to 
provide completely resolved epoxide and diol, a process that 
has been used to prepare a cumulative total of > 700 kg of 
resolved propylene oxide (Chirex, Dudley, UK; E.N. Jacob- 
sen, personal communication). It is also worth noting that 
for this particular substrate, the (salen)Co system represents 
the most enantioselective route for the preparation of the 
diol as well as the epoxide. The only apparent limitation of 
this chemistry is the narrow substrate scope, which is, ironi- 
cally, enzyme-like. The system is still under investigation, 
however; efforts to expand the method to include other 
epoxide substitution patterns are underway, as are synthetic 
applications (E.N. Jacobsen, unpublished observations). 
HKR of a trisubstituted alkyl epoxide using a 
catalytic antibody. Catalyst weight was 
calculated by assuming a molecular weight of 
150,000 (150 kDa) for the monoclonal 
antibody. 
r 
antibody 14D9 
Weight of 
substrate 
Weight of 
catalyst 
Volumetric 
productivity 
Yield 
Epoxide Diol 
ee 
Epoxide Diol 
0.24 mg 11 mg <0.13g1-1 - - 87% 
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Figure 10 
HKR of terminal epoxides with a synthetic 
catalyst. Volumetric productivities were 
calculated based on epoxide yield only; 
* denotes data after one recrystallization. VW-1 
- Rd” + 
‘Salen’ is the common name for the type of 
= 0.5 equiv Ha0 organic chelating ligand wrapped around the 
Cfl \ , 
I 
cobalt centre in (RR)-1, and the catalyst is 
X = PhCOr I thus referred to as a ‘(sale&o’ complex. The 
ligand shown is commercially available, but 
Weight of Weight of Volumetric Yield 
R substrate catalyst productivity Epoxide Diol Epoxiii Diol 
can also be readily prepared by the 
condensation of a chiral diamine (in this case, 
(RR)-cyclohexanediamine) with two 
CHz 589 1.4 g =325g 1-I 44% 50% >98% 98% equivalents of the appropriate o&o-hydroxy 
=225g I-’ 
aromatic aldehyde. This ligand has been 
CHsCl IOOg 2.3 g 44% 38% 98% 86% successfully employed in the Jacobsen 
asymmetric epoxidation and asymmetric ring- 
opening reactions as well 14,261. Ph 409 0.5 g =375g I-' 38% 39%* 98% 98%* 
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Future directions and opportunities 
Enzymatic and antibody catalysts will have to become 
more accessible to synthetic chemists to become more 
widely used. There are a number of ways in which this 
change might be effected. For example, the current 
experimental procedures could be brought into synthetic 
chemists’ regimen through increased training or collabora- 
tion. It would also help if enzyme or antibody preparations 
were commercially available. (Note that to provide access 
to a wide substrate pool, a number of these catalysts would 
have to be commercialized). Although not a trivial under- 
taking, the success of commercially available hydrolytic 
enzymes for the kinetic resolution of racemic chiral esters 
suggests that this is not out of the question. Alternatively, 
current methodology could be improved to the point that 
it can be carried out on an industrial scale. At least for 
simple epoxides, which are to be used at the early stages 
of a synthesis, many chemists would actually be happier 
purchasing the enantiomerically pure material rather than 
making it themselves. Again, although this would be no 
small task, the laudable resolution of p-nitrostyrene oxide 
(Figure 8) and the interest of a major pharmaceutical 
company in the epoxide hydrolase-catalyzed resolution of 
indene oxide indicate that such possibilities are being 
actively investigated [24]. 
Further application of the (salen)Co-catalyzed HKR will 
probably depend on whether the method can be extended 
to substrates other than terminal epoxides. Although it is not 
possible to predict the future of a new asymmetric catalyst 
system on the basis of a single report, the fact that (salen)Co 
complexes catalyze the enantioselective ring-opening of 
substituted epoxides (such as cyclohexene oxide) with other 
nucleophiles bodes well for future efforts [25]. 
The HKR of terminal and alkyl epoxides will clearly have a 
secure place among valued asymmetric catalytic methods, 
at least until direct enantioselective epoxidation of olefins 
becomes a viable option. Even if such direct epoxidations 
are developed, they will have to match or exceed the eff- 
ciencies of current HKR procedures to be truly competitive 
and with the standard now set by the (salen)Co HKR 
system, this will be no mean feat. 
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